National roll-out of latent tuberculosis testing and treatment for new migrants in England: A retrospective evaluation in a high-incidence area

Miranda G. Loutet*, Matthew Burman, Nivenka Jayasekera, Duncan Trathen, Susan Dart, Heinke Kunst, Dominik Zenner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Latent tuberculosis infection (LTBI) screening is an important intervention for tuberculosis (TB) elimination in low-incidence countries and is, therefore, a key component of England’s TB control strategy. This study describes outcomes from a LTBI screening programme in a high-incidence area to inform national LTBI screening in England and other low-incidence countries. We conducted a retrospective cohort study of LTBI screening among eligible migrants (from high-incidence countries and entered the UK within the last 5 years), who were identified at primary-care clinics in Newham, London between August 2014 and August 2015. Multivariable logistic regression was used to identify factors associated with LTBI testing uptake, interferon-γ release assay (IGRA) positivity and treatment uptake. 40% of individuals offered LTBI screening received an IGRA test. The majority of individuals tested were 16–35 years old, male and born in India, Bangladesh or Pakistan. Country of birth, smoking status and co-morbidities were associated with LTBI testing uptake. IGRA positivity was 32% among those tested and was significantly associated with country of birth, age, sex and co-morbidities. This study identifies factors associated with screening uptake, IGRA positivity and treatment uptake, and improves understanding of groups that should be supported to increase acceptability of LTBI testing and treatment in the community.

Original languageEnglish
Article number1701226
JournalEuropean Respiratory Journal
Volume51
Issue number1
DOIs
Publication statusPublished - 2018

Bibliographical note

Funding Information:
Support statement: M. Burman was funded by Bart's Charity and D. Zenner is affiliated with the National Institute for Health Research Health Protection Research Unit (NIHRHPRU) in Respiratory Infections at Imperial College London in partnership with Public Health England (PHE). The research received funding from the NIHR HPRU in Respiratory Infections at Imperial College London in Partnership with PHE. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, the Department of Health or PHE. Funding information for this article has been deposited with the Crossref Funder Registry.

Publisher Copyright:
Copyright ©ERS 2018.

Fingerprint

Dive into the research topics of 'National roll-out of latent tuberculosis testing and treatment for new migrants in England: A retrospective evaluation in a high-incidence area'. Together they form a unique fingerprint.

Cite this